📣 VC round data is live. Check it out!

RTW Biotech Opportunities Valuation Multiples

Discover revenue and EBITDA valuation multiples for RTW Biotech Opportunities and similar public comparables like Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji and more.

RTW Biotech Opportunities Overview

About RTW Biotech Opportunities

RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon. Geographically, it operates in U.S. &Canada, UK & EU, and Rest of the world.


Founded

2017

HQ

United Kingdom

Employees

0

Website

rtwbio.com

Financials (FY)

Revenue: $251M
Net Income: $245M

EV

$706M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

RTW Biotech Opportunities Financials

RTW Biotech Opportunities reported last fiscal year revenue of $251M.

In the same fiscal year, RTW Biotech Opportunities generated $245M in net income.


RTW Biotech Opportunities P&L

In the most recent fiscal year, RTW Biotech Opportunities reported revenue of $251M and net income of $245M.

RTW Biotech Opportunities is profitable as of last fiscal year, with net margin of 98%.

See analyst estimates for RTW Biotech Opportunities
Last FY202320242025202620272028
Revenue$251M$86M$39M$251M
Net Profit$245M$83M$34M$245M
Net Margin98%96%88%98%

Financial data powered by Morningstar, Inc.

RTW Biotech Opportunities Stock Performance

RTW Biotech Opportunities has current market cap of $706M, and enterprise value of $706M.

Market Cap Evolution


RTW Biotech Opportunities' stock price is $2.18.

RTW Biotech Opportunities share price increased by 1.4% in the last 30 days, and by 90.4% in the last year.

RTW Biotech Opportunities has an EPS (earnings per share) of $0.76.

See more trading valuation data for RTW Biotech Opportunities
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$706M$706M0.9%1.4%4.3%90.4%$0.76

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

RTW Biotech Opportunities Valuation Multiples

RTW Biotech Opportunities trades at 2.8x EV/Revenue multiple.

See NTM and 2027E valuation multiples for RTW Biotech Opportunities

RTW Biotech Opportunities Financial Valuation Multiples

As of May 9, 2026, RTW Biotech Opportunities has market cap of $706M and EV of $706M.

RTW Biotech Opportunities has a P/E ratio of 2.9x.

Last FY202320242025202620272028
EV/Revenue2.8x8.2x18.2x2.8x
P/E2.9x8.5x20.6x2.9x
EV/FCF6.7x21.0x(5.7x)6.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified RTW Biotech Opportunities Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

RTW Biotech Opportunities Margins & Growth Rates

In the most recent fiscal year, RTW Biotech Opportunities reported net margin of 98%.

See estimated margins and future growth rates for RTW Biotech Opportunities

RTW Biotech Opportunities Margins

Last FY20242025202720282029
Net Margin98%88%98%
FCF Margin42%(321%)42%

RTW Biotech Opportunities Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(55%)548%
Net Profit Growth(59%)617%
FCF Growth(471%)(185%)

Data powered by FactSet, Inc. and Morningstar, Inc.

RTW Biotech Opportunities Operational KPIs

Access forward-looking KPIs for RTW Biotech Opportunities
Last FY202320242025202620272028
G&A Expenses to Revenue2%4%12%2%
Opex to Revenue2%4%12%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

RTW Biotech Opportunities Competitors

RTW Biotech Opportunities competitors include Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji, Qualitas Real Estate, Investment AB Oresund, TINC, Thornburg Inc Builder, Platinum Capital and Regal Partners.

Most RTW Biotech Opportunities public comparables operate across Asset Management and PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Noah Holdings(0.0x)(0.0x)(0.1x)(0.1x)
Wereldhave Belgium10.0x13.5x15.8x
Vinci Partners2.9x2.8x7.2x9.3x
Mogan Enerji5.7x14.5x
Qualitas Real Estate11.4x13.8x
Investment AB Oresund7.5x
TINC10.5x9.9x15.9x14.4x
Thornburg Inc Builder6.7x

This data is available for Pro users. Sign up to see all RTW Biotech Opportunities competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About RTW Biotech Opportunities

When was RTW Biotech Opportunities founded?RTW Biotech Opportunities was founded in 2017.
Where is RTW Biotech Opportunities headquartered?RTW Biotech Opportunities is headquartered in United Kingdom.
How many employees does RTW Biotech Opportunities have?As of today, RTW Biotech Opportunities has over 0 employees.
Is RTW Biotech Opportunities publicly listed?Yes, RTW Biotech Opportunities is a public company listed on London Stock Exchange.
What is the stock symbol of RTW Biotech Opportunities?RTW Biotech Opportunities trades under RTW ticker.
Who are competitors of RTW Biotech Opportunities?RTW Biotech Opportunities main competitors include Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji, Qualitas Real Estate, Investment AB Oresund, TINC, Thornburg Inc Builder, Platinum Capital, Regal Partners.
What is the current market cap of RTW Biotech Opportunities?RTW Biotech Opportunities' current market cap is $706M.
What is the current revenue of RTW Biotech Opportunities?RTW Biotech Opportunities' last fiscal year revenue is $251M.
What is the current EV/Revenue multiple of RTW Biotech Opportunities?Current revenue multiple of RTW Biotech Opportunities is 2.8x.
Is RTW Biotech Opportunities profitable?No, RTW Biotech Opportunities is not profitable.
How many companies RTW Biotech Opportunities has acquired to date?RTW Biotech Opportunities hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies RTW Biotech Opportunities has invested to date?RTW Biotech Opportunities hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to RTW Biotech Opportunities

Lists including RTW Biotech Opportunities

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial